Saturday, January 14, 2017 4:01:31 PM
It is rather obvious after 10 years of documentation, that any manipulation taking place in these scams is solely done by insiders dumping shares.
Giving cute names like CE's to deflect insider selling while using the debunked daily short interest report is why anyone who believed
this bull$hit is down 95% on their investments.
Sad
---------------------------
we will agree to disagree
the OTC where PTOI currently resides was the CEs' *totally fungible* playground and *retail*
was their candy ..
it's why patterns matter and documentation provokes ..
as i've noted elsewhere based on my personal *hedge* re: P2O/PTOI
when retail recognizes what .. when .. who and how .. *retail* can *work* CEs' predictable patterns
which *imo* PTOI will reveal over the coming days
if CEs' *cant* break 3c *decisively* (cant be obvious wash traded volume like 12.23.16 was) .. ;)
and do so with *volume* .. CEs' have less than squat .. and if that comes to pass .. *zero doubts*
actual P2O investors (like the LT investor who picked off over 1M over 6 weeks from LL's infusion
.. 8K filed .. last week of August 2016 .. to the first week of October 2016) will see PTOI bids begin to stack
watching to see how *handled* via VNDM's elastic 10000 (aka abusive) @ 051 .. ;)
CEs' lose 5c .. 10c is then on tap .. CEs' lose 10c .. 20c is on tap ... CEs' lose 20c .. 35c is on tap
and if CEs' lose 35c .. imo (never been a chartist) .. CEs' *real* dilemma from 4 years ago this month
is then on tap .. and that is 1.50 to 1.65
btw and fyi .. i'm not referencing any new investors .. just actual LT P2O investors *comfortable* with their respective DD
4kids
Quote:
There are no colluding entities. The only foul play here is the founder making millions off his lies. I hope he ends up in prison
Excuses on the stock and companies poor performance only creates more potential for new investors to lose money.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM